A interactive resource offering patients and physicians clinical trial information.

Information about an NCI-funded program which facilitates participation in phase III clinical trials.

Comprehensive searchable registry presented by the U.S. National Cancer Institute.

Resource for clinical trials and research. Information about experimental anticancer drugs, chemotherapy treatment and cooperative groups.

Provides a clinical trial service matching and referral service for cancer patients. Includes contact details.

This firm is soliciting participants to a Phase II clinical trial with the hormonal agent toremifene for use in prostatic intraepithelial neoplasia which is thought to be a precursor condition to prostate cancer.

Details the working of a clinical trials matching program.

Overview guidance as presented by a cancer survivor.

General resource by the U.S. Food and Drug Administration.

Overview information as presented by this Houston, Texas hospital and research complex, as well as listings of ongoing institutional studies.

General information from this University of Pennsylvania source.

Description and trials listing related to basic science, clinical research, epidemiology control and patient care programs at this San Francisco, California institution.

Information about the use of Oncophage, an experimental vaccine treatment for this condition by the pharmaceutical firm, Antigenics.

Gives details about the clinical trial involving the use of Herceptin as adjuvant therapy in HER2-positive patients with primary breast cancer. This resource is designed for use by patients and investigators.

Gives information on cancer research including current trials, centers, events, meetings, and links.

Outlines aspects of this research study for skin cancer with the agent Verteporfin.

Discussion of melanoma by Antigenics, Inc. in the context of its vaccine therapy trials.

Allows users to search a database of research projects including clinical trials as supported by major US and UK funding organizations.

Outlines a current study about the influence of diet and physical activity. Conducted by the University of South Carolina and the Palmetto Health system.

Outlines the terms and progress of a research study related to cancer risk communication in hereditary breast, ovarian and colorectal cancers.

Discussion of chronic myelogenous leukemia by the Antigenics firm and its cancer vaccine trial for AG-858.

Information presented by a UK non-profit organization about a clinical trial for pleural mesothelioma.

Research study underway for newly diagnosed women living in the greater Los Angeles area.

General information as presented by this support organization with links to trial finder services for prostate cancer.

Research programs and current studies at the City of Hope cancer center in Duarte, California.

This UK research inquiry will evaluate over 100,000 subjects to help determine causes of breast cancer.

Details the research study by Stanford University for this treatment method of breast cancer.

Presents the work of Dr. David Christiani and his team at the Harvard School of Public Health on risk factors and treatment response.

Phase III clinical study with Transferrin-CRM107 for this type of brain tumor.

Washington University institution seeks patient volunteers for a genetic research project.

Phase II clinical trial for hormone-refractory disease by the MGI Pharma company.

Details information on clinical studies for this condition that use the Telik firm's drug-agent TLK286.

Biotech firm is seeking clinical participants for the evaluation of their blood test to detect breast cancer.

Describes a scientific inquiry on the genetic and environmental risk factors for breast cancer.

Evaluates innovative and promising methods and approaches to cancer treatment through clinical studies.

Discussion of targeted anti-cancer therapies by Pfizer. Includes links to general information, and to clinical trial data and information.

Information about a European study on cancer patients survival and care. Related data files are available for download.

Compares single-day targeted intra-operative radiotherapy to conventional post-operative radiotherapy for breast cancer.